At the beginning of June, the Texas Department of State Health Services asked all programs funded by the CDC’s HIV Prevention ...

The Supreme Court on Friday granted the HIV-prevention field a historic win — yet with a major caveat — as it upheld a ...

Lenacapavir is a major step forward in HIV prevention. With just two injections a year, it is a simple and highly effective ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

With National HIV Testing Day on June 27, Richmond and Henrico Health Districts officials are encouraging people who may be ...

Chicagoland research labs and community clinics are navigating illegal funding stoppages, censorship, and increasing ...

Yetzugo is a long-acting HIV-1 capsid inhibitor that reduces the risk of sexually acquired HIV in adults and adolescents.

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...